A

Ataxion, Inc.

50 employees

Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.

Basic info

Industry

research services

Sectors

Biotechnology
Pharmaceutical
Life Science

Date founded

2013

Funding rounds raised

Total raised

$17M

from 2 investors over 2 rounds

A

Ataxion, Inc. raised $17M on March 17, 2014

Investors: Biogen Idec and Atlas Venture

FAQ